apt4982-sup-0001-TableS1.docWord document73KTable S1.Priority 1 proteins differentially expressed between hepatocellular, cholestatic and mixed DILI.
apt4982-sup-0002-TableS2.docWord document116KTable S2.Priority 1 proteins differentially expressed between mild, moderate and severe/fatal DILI.
apt4982-sup-0003-TableS3.docWord document55KTable S3.Priority 1 proteins differentially expressed between definite and possible DILI.
apt4982-sup-0004-TableS4.docWord document122KTable S4.Priority 1 proteins with significant differential expression throughout the 6-month follow-up period in the longitudinal analysis.
apt4982-sup-0005-TableS5.docWord document179KTable S5.Priority 1 proteins differentially expressed between DILI patients and controls.
apt4982-sup-0006-TableS6.docWord document92KTable S6.27 differentially expressed common priority 1 proteins identified in both the DILI and NAFLD serum proteomic analyses.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.